All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
This is a summary of the NHS Devon commissioning policy for Myringotomy with or without ventilation tubes (grommets) in adults and children aged 12 years and older
Children under 12 years – see Myringotomy/grommets with or without adjuvant adenoidectomy for the management of otitis media in children under 12 years
Myringotomy with or without ventilation tubes (grommets) will only be funded if the following criteria are met:
Persistent otitis media with effusion (OME) – There has been a period of at least three months watchful waiting* from the date of diagnosis of OME (by GP/primary care referrer/audiologist/ENT surgeon) and OME persists after three months andthe patient suffers from persistent bilateral OME with a hearing level in the better ear of 25 dBHL (averaged at 0.5, 1, 2, and 4 kHz) or worse, confirmed at three months†.
Or
To aid intratympanic administration of medicines
Or
Where middle ear ventilation is an essential feature of specialist investigation for, or management of:
*During the watchful waiting period, advice on lifestyle modifications such as stopping smoking (and if appropriate advice on educational and behavioural strategies to minimise the effects of hearing loss) should be offered. The patient's hearing should be re-tested at the end of this time.
†Good practice point: ensure OME has not resolved once a date of surgery has been agreed, with tympanometry as a minimum
Where the circumstances of treatment for an individual patient do not meet the criteria described above exceptional funding can be sought. Individual cases will be reviewed by the appropriate panel of NHS Devon upon receipt of a completed application from the patient's GP, consultant or clinician. Applications cannot be considered from patients personally.
Applications for consideration for funding approval should be sent to:
Email: d-icb.ifr-newsdt@nhs.net
Publication date: 28 October 2019